Trials / Completed
CompletedNCT01833793
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
Mirena and Amenorrhea Related acceptabILity in Contraception indIcAtion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
MARILIA is a prospective, non-interventional, multicenter study. The purpose of this study is to describe the acceptability of Amenorrhea in contraception indication of Mirena users during one year follow up in medical practice. 500 patients in 20 centers will be enrolled in the study. Bleeding profile, removal or non-removal of the IUS (IntraUterine System) will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levonorgestrel IUD (Mirena, BAY86-5028) | Women who have been prescribed Mirena in contraception; followed up for 12 months |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-11-01
- Completion
- 2015-05-01
- First posted
- 2013-04-17
- Last updated
- 2015-09-14
Locations
1 site across 1 country: Algeria
Source: ClinicalTrials.gov record NCT01833793. Inclusion in this directory is not an endorsement.